• About Us
    • Our Story
    • Values & Commitment
    • Our Process
    • Meet the Team
    • Our Partners
  • Compliance Services
    • Cell & Gene Therapy
    • Pharmaceutical Drugs
    • Medical Devices
    • FDA 483 / Warning Letter
    • US Agent & Official Correspondent
    • Audits
    • Compliance Without the Attorney Fees
    • Dietary Supplement
    • Facility Registration & Listing
    • FDA Compliance
    • Good Supply Practice
    • Modernization of Cosmetics Regulation Act
    • Quality Culture
    • Product Recalls
    • Quality Systems
    • Regulatory Affairs
    • Training
    • Virtual Quality Assurance
  • Expertise
    • Pharmaceutical
    • Medical Devices
    • Clinical
    • Biologics
  • Resources
    • Compliance Insight Blog
    • GXP Infusion
    • Quality Assurance Accreditation
    • Success Stories
    • Videos and Media
    • White Papers And Downloads
  • Search
  • Contact
Compliance Insight
Skip to content
  • About Us
    • Our Story
    • Values & Commitment
    • Our Process
    • Meet the Team
    • Our Partners
  • Compliance Services
    • Cell & Gene Therapy
    • Pharmaceutical Drugs
    • Medical Devices
    • FDA 483 / Warning Letter
    • US Agent & Official Correspondent
    • Audits
    • Compliance Without the Attorney Fees
    • Dietary Supplement
    • Facility Registration & Listing
    • FDA Compliance
    • Good Supply Practice
    • Modernization of Cosmetics Regulation Act
    • Quality Culture
    • Product Recalls
    • Quality Systems
    • Regulatory Affairs
    • Training
    • Virtual Quality Assurance
  • Expertise
    • Pharmaceutical
    • Medical Devices
    • Clinical
    • Biologics
  • Resources
    • Compliance Insight Blog
    • GXP Infusion
    • Quality Assurance Accreditation
    • Success Stories
    • Videos and Media
    • White Papers And Downloads
  • Search
  • Contact

Blog

Share
  • Facebook
  • Twitter
  • LinkedIn
  • Email

March 27, 2020by TLM

Compliance Insight announces Virtual Quality Assurance solution to provide competitive advantage

March 19, 2020by TLM

FDA Issues Guidance for Conducting Clinical Trials

March 19, 2020by TLM

CLIA Waiver Final Guidance Documents

March 18, 2020by TLM

FDA Releases Temporary New Guidance on Hand Sanitizer

March 11, 2020by TLM

The World Health Organization just announced…

February 7, 2020by TLM

Ethylene Oxide Sterilization facility updates

February 6, 2020by TLM

FDA releases new guidance..

February 4, 2020by TLM

FDA published a revision to MAPP

January 28, 2020by TLM

Public meeting announcement..

January 21, 2020by TLM

Are you worried about the US Hemp rules??

January 18, 2020by TLM

Congratulations Compliance Insight!!

January 16, 2020by TLM

Data Integrity and GMP’s

November 13, 2019by TLM

The FDA is sending out a warning about Biotin

November 5, 2019by TLM

Did you know this about hemp??

October 31, 2019by TLM

CBD and dinner? You bet!

October 2, 2019by TLM

Don’t miss out on our President Cynthia Ipach speaking at LaunchBio! You won’t want to miss it!

October 1, 2019by TLM

What a SUCCESS!!

September 18, 2019by TLM

Good Supply Practices, what you need to know!

September 3, 2019by TLM

Do you know that NIPP includes quality culture?

August 28, 2019by TLM

Ohio Governor signs hemp legalization bill

August 27, 2019by TLM

Do you know what the FDA has to say about Good Supply Practices??

  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 10
  • Next Page »

Be in Touch

info@compliance-insight.com
p. 513-860-3512

Corporate Headquarters

497 Circle Freeway Suite 230
Cincinnati, Ohio 45246

Business Hours

Monday – Friday
8:30am EST – 5:30pm EST

Social

© 2025 by Compliance Insight All Rights Reserved | Contact Us

Privacy Policy | Terms of Use | Use of Cookies